Previous close | 121.07 |
Open | 120.00 |
Bid | 121.83 x 500 |
Ask | 121.93 x 500 |
Day's range | 119.50 - 122.82 |
52-week range | 62.55 - 142.79 |
Volume | |
Avg. volume | 3,959,642 |
Market cap | 46.713B |
Beta (5Y monthly) | 1.59 |
PE ratio (TTM) | N/A |
EPS (TTM) | -15.60 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 137.73 |
Moderna stock broke out of a cup-with-handle base after its first-quarter sales and earnings report. Is MRNA stock a buy right now?
Calpers slashed investments in Verizon, Disney, and Peloton stock, and doubled down on Moderna shares in the first quarter.
Moderna, Inc. (NASDAQ:MRNA) Q1 2024 Earnings Call Transcript May 2, 2024 Moderna, Inc. beats earnings expectations. Reported EPS is $-3.07, expectations were $-3.56. MRNA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. […]